NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
ALDURAZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
09/12/2023
Trademark type
Word
Nice classes
5
Filing date
02/24/2000
Registration date
10/22/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
09/03/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2002
First use in commerce
06/01/2002
Drawing code
1
Owner type
16
Owner location
Cambridge, MA
Examiner
MICHOS, JOHN E
Law office
L50
Current location
POST REGISTRATION
Holders and representatives
Holders
BioMarin/Genzyme LLC
Representatives
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug for treating lysosomal storage diseases
Publications
History of USPTO decisions and trademark events.
40 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/08/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/08/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/08/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/24/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
01/05/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/05/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/22/2021
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/20/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/20/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/20/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/20/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/07/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/07/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/07/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/07/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
11/12/2012
CFIT
CASE FILE IN TICRS
02/12/2008
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/18/2007
PLGL
ASSIGNED TO PARALEGAL
10/30/2007
E815
TEAS SECTION 8 & 15 RECEIVED
10/22/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/22/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/22/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2002
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/10/2002
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/02/2002
IUAF
USE AMENDMENT FILED
07/25/2002
EISU
TEAS STATEMENT OF USE RECEIVED
07/24/2002
EX1G
SOU EXTENSION 1 GRANTED
02/09/2002
EXT1
SOU EXTENSION 1 FILED
01/29/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/21/2001
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/08/2001
PUBO
PUBLISHED FOR OPPOSITION
12/05/2000
NPUB
NOTICE OF PUBLICATION
11/03/2000
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2000
DOCK
ASSIGNED TO EXAMINER
07/27/2000
Continuous trademark protection
Get notified about every new filing that threatens ALDURAZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.